IMedis is a medical artificial intelligence startup, that is developing a proprietary and patent pending platform for surfacing patients with undetected findings that are candidates for early and preventative care. Established in 2018 following a $1M seed, IMedis has 6 employees and offices in Israel and the US. The platform is currently installed in 2 large hospitals and in a clinical trial as well as being evaluated by global HealthIT vendors.